Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Waters

Showing results (931-940 of 962) with videos related to

Pageof 97
Sort By:
Nature Communications|December 6, 2023
Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variationElizabeth J Radford, Hong-Kee Tan, Malin H L Andersson, et al.
The Lancet. HIV|December 1, 2023
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessmentAnn K Sullivan, John Saunders, Monica Desai, et al.
Cell|September 19, 2024
High-resolution functional mapping of RAD51C by saturation genome editingRebeca Olvera-León, Fang Zhang, Victoria Offord, et al.
Blood|May 5, 2018
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M Stein, Guillermo Garcia-Manero, David A Rizzieri, et al.
Journal of Inherited Metabolic Disease|August 7, 2023
Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1K van Vliet, A M Dijkstra, M J Bouva, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 InhibitorLorna H Mitchell, P Ann Boriack-Sjodin, Sherri Smith, et al.
Human Mutation|June 12, 2008
Molecular and clinical genetics of mitochondrial diseases due to POLG mutationsLee-Jun C Wong, Robert K Naviaux, Nicola Brunetti-Pierri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
JAMA Dermatology|May 27, 2026
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained IndividualsAlisa M Goldstein, Jung Kim, Jeremy S Haley, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Pageof 97

Showing results (931-940 of 962) with videos related to

Sort By:
Pageof 97
Nature Communications|December 6, 2023
Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variationElizabeth J Radford, Hong-Kee Tan, Malin H L Andersson, et al.
The Lancet. HIV|December 1, 2023
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessmentAnn K Sullivan, John Saunders, Monica Desai, et al.
Cell|September 19, 2024
High-resolution functional mapping of RAD51C by saturation genome editingRebeca Olvera-León, Fang Zhang, Victoria Offord, et al.
Blood|May 5, 2018
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemiaEytan M Stein, Guillermo Garcia-Manero, David A Rizzieri, et al.
Journal of Inherited Metabolic Disease|August 7, 2023
Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1K van Vliet, A M Dijkstra, M J Bouva, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 InhibitorLorna H Mitchell, P Ann Boriack-Sjodin, Sherri Smith, et al.
Human Mutation|June 12, 2008
Molecular and clinical genetics of mitochondrial diseases due to POLG mutationsLee-Jun C Wong, Robert K Naviaux, Nicola Brunetti-Pierri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
JAMA Dermatology|May 27, 2026
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained IndividualsAlisa M Goldstein, Jung Kim, Jeremy S Haley, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Pageof 97